| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/09/2007 | US20070184078 Packaging system |
| 08/09/2007 | US20070184077 Container |
| 08/09/2007 | US20070184076 Liquid-filled nanodroplets for anti-cancer therapy |
| 08/09/2007 | US20070184050 Stable water-based medicinal preparation containing antibody |
| 08/09/2007 | US20070183989 Oral Compositions Comprising Zinc Citrate and/or Tocopherol Agents |
| 08/09/2007 | US20070183984 Calcium phosphate salts in oral compositions suitable as a tooth remineralizing agent |
| 08/09/2007 | US20070183983 Medical composition containing nf-kb decoy for treating and preventing respir atory diseases and method of using the same |
| 08/09/2007 | US20070183982 Pharmaceutical composition for aerosols with two or more active substances and at least one surfactant |
| 08/09/2007 | US20070183980 Thermoforming by extrusion without discoloration; controlled release |
| 08/09/2007 | US20070183979 Heat pressing a mixture of an active ingredient with abuse potential, a high strength polymer, and a wax into a controlled release dosage form |
| 08/09/2007 | US20070183974 Method and apparatus for production of a skin graft and the graft produced thereby |
| 08/09/2007 | US20070183955 Hydroxyapaltite calcium phosphate granules, method for preparing same and uses thereof |
| 08/09/2007 | US20070182040 Method for preparation of microsphere and apparatus therefor |
| 08/09/2007 | US20070181124 Method and apparatus for dispensing inhalator medicament |
| 08/09/2007 | DE20321445U1 Otorhinologische Abgabevorrichtung Otorhinologische dispenser |
| 08/09/2007 | DE20221765U1 Behältnis mit Bestandteilen eines Dialysekonzentrates und Vorrichtung zur Aufbereitung solcher Behältnisse Container with components of a dialysis concentrate and apparatus for the treatment of such containers |
| 08/09/2007 | DE10066158B4 Verwendung eines transdermalen therapeutischen Systems zur Behandlung des Restless-Legs-Syndroms Use of a transdermal therapeutic system for the treatment of Restless Legs Syndrome |
| 08/09/2007 | CA2641819A1 Composition for promoting vascular smooth muscle relaxation |
| 08/09/2007 | CA2641146A1 Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof |
| 08/09/2007 | CA2640731A1 Methods of making medical devices |
| 08/09/2007 | CA2640598A1 Liposome preparation |
| 08/09/2007 | CA2640557A1 Nanoparticles designed for drug delivery |
| 08/09/2007 | CA2640531A1 Enterically coated cysteamine, cystamine and derivatives thereof |
| 08/09/2007 | CA2640460A1 Drug delivery systems comprising weakly basic selective serotonin 5-ht3 blocking agent and organic acids |
| 08/09/2007 | CA2640458A1 Lipoparticles comprising ion channels, methods of making, and using the same |
| 08/09/2007 | CA2640382A1 Drug delivery systems comprising weakly basic drugs and organic acids |
| 08/09/2007 | CA2640030A1 Biodegradable non-ophthalmic implants and related methods |
| 08/09/2007 | CA2637846A1 A topical composition comprising an antibacterial substance |
| 08/09/2007 | CA2637678A1 Rna silencing agents for use in therapy and nanotransporters for efficient delivery of same |
| 08/09/2007 | CA2637316A1 A pharmaceutical composition comprising perindopril |
| 08/09/2007 | CA2636061A1 Flavor-enhancing compositions, methods of manufacture, and methods of use |
| 08/09/2007 | CA2634879A1 Pharmaceutical formulations of oxcarbazepine and methods for its preparation |
| 08/09/2007 | CA2633762A1 Unit dose comprising water-insoluble inorganic phosphate binder |
| 08/09/2007 | CA2632871A1 Sutures and fibrosing agents |
| 08/09/2007 | CA2630675A1 Transdermal therapeutic system for volatile and/or thermolabile substances |
| 08/09/2007 | CA2630240A1 Oxcarbazepine pharmaceutical formulation and its method of preparation, wherein oxcarbazepine has a broad and multi-modal particle size distribution |
| 08/08/2007 | EP1816138A1 Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 08/08/2007 | EP1815869A1 Method of changing morphology of block copolymer |
| 08/08/2007 | EP1815868A2 Drug absorptivity improving agent |
| 08/08/2007 | EP1815865A1 Therapeutic agent for diabetes comprising protease-inhibiting compound |
| 08/08/2007 | EP1815857A1 A pharmaceutical composition comprising perindopril |
| 08/08/2007 | EP1815855A1 Pharmaceutical composition for modified release insulin sensitiser |
| 08/08/2007 | EP1815852A1 Nonaqueous preparation for percutaneous absorption containing nonsteroidal antiflammatory analgesic |
| 08/08/2007 | EP1815851A1 Nanoparticles designed for drug delivery |
| 08/08/2007 | EP1815850A1 Controlled release formulation of divalproic acid and its derivatives |
| 08/08/2007 | EP1815849A1 Oxcarbazepine pharmaceutical formulation and its method of preparation, wherein oxcarbazepine has a broad and multi-modal particle size distribution |
| 08/08/2007 | EP1815848A1 Antibody fragment-targeted immunoliposomes for systemic gene delivery |
| 08/08/2007 | EP1815847A2 Aggregate with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin |
| 08/08/2007 | EP1815846A2 Aggregate with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin |
| 08/08/2007 | EP1815845A2 Biocompatible compounds for pharmaceutical drug delivery systems |
| 08/08/2007 | EP1814985A2 Stabilisation of granules comprising active compounds |
| 08/08/2007 | EP1814843A1 Stable crystalline modifications of dotap chloride |
| 08/08/2007 | EP1814651A2 Process and device for producing finely divided liquid-liquid formulations, and the uses of these liquid-liquid formulations |
| 08/08/2007 | EP1814594A2 Vector comprising polymer modified sirna liposomes |
| 08/08/2007 | EP1814593A1 An oral preparation having improved bioavailability |
| 08/08/2007 | EP1814558A2 Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis |
| 08/08/2007 | EP1814531A2 Transdermal delivery systems |
| 08/08/2007 | EP1814530A2 Dihydropyrimidine microcapsule-formulations |
| 08/08/2007 | EP1814529A1 Dosage form time-lagged of drugs for the therapy of insomnia |
| 08/08/2007 | EP1814528A2 Process for making a highly compressible controlled delivery compositions of metformin |
| 08/08/2007 | EP1814527A1 Bilayer tablet comprising telmisartan and amlodipine |
| 08/08/2007 | EP1814526A2 Oral solid dosage forms containing a low dose of estradiol |
| 08/08/2007 | EP1814525A2 Stable lyophilized anthracycline glycosides |
| 08/08/2007 | EP1814524A1 Solid, oral, microparticulate dosage form which has been designed to prevent misuse |
| 08/08/2007 | EP1814523A1 Solid, oral drug form which has been designed to prevent misuse |
| 08/08/2007 | EP1814522A1 Method of formation of the shape-retentive aggregates of gel particles and their uses |
| 08/08/2007 | EP1814521A1 Dry powder inhaler formulations comprising surface-modified particles with anti- adherent additives |
| 08/08/2007 | EP1814520A1 Pharmaceutical compositions comprising a camtothecin derivate |
| 08/08/2007 | EP1814519A1 Active substance delivery system comprising a hydrogel atrix and microcarriers |
| 08/08/2007 | EP1814518A1 Triple natural polymer viscoelastic composition |
| 08/08/2007 | EP1814517A1 Nonaqueous liquid parenteral aceclofenac formulation |
| 08/08/2007 | EP1814516A1 Use of a liquid allergy vaccine formulation for oromucosal administration |
| 08/08/2007 | EP1814515A1 Ophthalmic compositions comprising polyether substituted polymers |
| 08/08/2007 | EP1814514A2 Heavy chain and single domain antibodies |
| 08/08/2007 | EP1814512A2 Peroral dosage forms to achieve a sustained-release effect after medicament dosage with a meal |
| 08/08/2007 | EP1723172B1 Erythropoietin liquid formulation |
| 08/08/2007 | EP1701709A4 Confection product containing urea |
| 08/08/2007 | EP1664044B1 S-tenatoprazole sodium monohydrate salt and the use thereof in the form of a proton pump inhibitor |
| 08/08/2007 | EP1596870B1 High dose ibandronate formulation |
| 08/08/2007 | EP1595537B1 Buccal cavity treatment composition and corresponding uses thereof |
| 08/08/2007 | EP1539109A4 Block copolymer micelle composition having an enhanced drug-loading capacity and sustained release |
| 08/08/2007 | EP1536767B1 Osmotic delivery system with early zero order push power engine comprising an osmotic agent dispersed in the fluid vehicle |
| 08/08/2007 | EP1487832B1 Micronized crystalline tiotropium bromide |
| 08/08/2007 | EP1482938B1 Pharmaceutical composition of a pde4 or a pde3/4 inhibitor and a histamine receptor antagonist |
| 08/08/2007 | EP1474110B1 Depot medicaments with new conjugated carriers |
| 08/08/2007 | EP1471908B1 Process for preparing losartan potassium with improved flowability |
| 08/08/2007 | EP1441713B1 Modified release tamsulosin tablets |
| 08/08/2007 | EP1432681B1 Pseudopolymorphic forms of carvedilol |
| 08/08/2007 | EP1423124B1 Lyophilized formulation comprising olanzapine |
| 08/08/2007 | EP1392248B1 Implant manufacturing process by means of solvent free preparation of a homogenate |
| 08/08/2007 | EP1360169B1 Succinate salt of o-desmethyl-venlafaxine |
| 08/08/2007 | EP1359902B1 Bimodal dry powder formulation for inhalation |
| 08/08/2007 | EP1357870B1 Bioadhesive cell foam film of sustained-release delivery |
| 08/08/2007 | EP1343530B1 Oral pharmaceutical composition containing a block copolymer |
| 08/08/2007 | EP1339389A4 Compositions for sustained delivery of hydrophobic drugs and process for the preparation thereof |
| 08/08/2007 | EP1315509B1 Nitrogen oxide for use in the treatment of drug resistant organisms |
| 08/08/2007 | EP1280514B1 Evaporative coolant comprising hydrofluorocarbons |
| 08/08/2007 | EP1071425B1 Treatment of depression and pharmaceutical preparations therefor |
| 08/08/2007 | EP1021137B1 Drug delivery system |
| 08/08/2007 | EP0910402B1 Insulin preparations containing mannitol |